In vivo evidence for the role of lipoprotein lipase activity in the regulation of apolipoprotein AI metabolism: A kinetic study in control subjects and patients with type II diabetes mellitus

Journal of Clinical Endocrinology and Metabolism

Volumn 86, Issue 5, 2001, Pages 1962-1967

  Frenais R ^a   Nazih, H ^a   Ouguerram, K ^a   Maugeais, C ^a   Zair Y ^b   Bard, J M ^a   Charbonnel, B ^b   Magot, T ^a   Krempf, M ^a,b,c  

^a INSERM   (France)

^b HÔTEL DIEU   (France)

^c Clinique d'Endocrinologie Hotel Dieu CHU de Nantes   (France)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN LIPASE; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; ENZYME ACTIVITY; FEMALE; HUMAN; LIPID METABOLISM; LIPOPROTEIN BLOOD LEVEL; MALE; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; APOLIPOPROTEIN A-I; CARRIER PROTEINS; CHILD; CHOLESTEROL ESTER TRANSFER PROTEINS; DIABETES MELLITUS, TYPE 2; FEMALE; GLYCOPROTEINS; HUMANS; KINETICS; LIPOPROTEIN LIPASE; LIPOPROTEINS, HDL; MALE; MIDDLE AGED;

EID: 0034997706     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.86.5.1962     Document Type: Article

References (47)

1. Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR. 1977 High density lipoprotein as a protective factor against coronary heart disease: the Framingham study. Am J Med. 62:707-714.
2. Saku K, Gartside PS, Hynd BA, Mendoza SG, Kashyap ML. 1985 Apolipoprotein AI and AII metabolism in patients with primary high density lipoprotein deficiency associated with familial hypertriglyceridemia. Metabolism. 34:754-764.
3. Brinton EA, Eisenberg S, Breslow JL. 1991 Increased apo AI and apo AII fractional catabolic rate in patients with low high density lipoprotein-cholesterol levels with or without hypertriglyceridemia. J Clin Invest. 87:536-544.
4. Patsch JR, Gotto AM, Olivecrona T, Eisenberg S. 1978 Formation of high density lipoprotein 2-like particles during lipolysis of very low density lipoproteins in vitro. Proc Natl Acad Sci USA. 75:4519-4523.
5. Eisenberg S. 1984 HDL metabolism. J Lipid Res. 25:1017-1058.
6. Nikkilä EA, Taskinen MR, Kekki M. 1978 Relation of plasma high density lipoprotein cholesterol to lipoprotein lipase activity in adipose tissue and skeletal muscle of man. Atherosclerosis. 29:497-501.
7. Nevin DN, Zambon A, Furlong CE, et al. 1996 Paraoxonase genotypes, lipoprotein lipase activity, and HDL. Arterioscler Thromb Vasc Biol. 16:1243-1249.
8. 2; relationship of the plasma level of this lipoprotein species to its composition, to the magnitude of postprandial lipemia, and to the activities of lipoprotein lipase and hepatic lipase. J Clin Invest. 80:341-347.
9. Kekki M. 1980 Lipoprotein lipase action in determining plasma high density lipoprotein cholesterol level in adult normolipaemics. Atherosclerosis. 37:143-150.
10. Magill P, Rao SN, Miller NE, et al. 1982 Relationships between the metabolism of high density and very low density lipoprotein in man: studies of apolipoprotein kinetics and adipose tissue lipoprotein lipase activity. Eur J Clin Invest. 12:113-120.
11. Kuusi T, Ehnholm C, Viikari J, et al. 1989 Postheparin plasma lipoprotein and hepatic lipase are determinants of hypo- and hyperalphalipoproteinemia. J Lipid Res. 30:1117-1126.
12. Crepaldi G, and Manzato E. 1988 Atherogenic factors in diabetes: the role of lipoprotein metabolism. Postgrad Med J. 64:10-12.
13. Taskinen MR, Nikkilä EA, Kuusi T, Harno K. 1982 Lipoprotein lipase activity and serum lipoproteins in untreated type II (insulin-independent) diabetes associated with obesity. Diabetologia. 22:46-50.
14. Agardh CD, Sartor G, Nilsson-Ehle P. 1983 Plasma high density lipoproteins and lipolytic enzyme activities in diabetic patients. Acta Med Scand. 213:123-128.
15. Zech LA, Schaefer EJ, Brewer Jr HB. 1978 Metabolism of plasma apolipoproteins AI and AII in man. Circulation. 58:11-40.
16. Goldberg IJ, Blaner WS, Vanni TM, Moukides M, Ramakrishnan R. 1990 Role of lipoprotein lipase in the regulation of high density lipoprotein apolipoprotein metabolism. Studies in normal and lipoprotein lipase-inhibited monkeys. J Clin Invest. 86:463-473.
17. Pfeifer MA, Brunzell JD, Best JD, Judzewitsc RG, Halter JB, Porte Jr D. 1983 The response of plasma triglyceride, cholesterol, and lipoprotein lipase of treatment in non insulin-dependent diabetic subjects without familial hypertriglyceridemia. Diabetes. 32:525-531.
18. Taskinen MR. 1987 Lipoprotein lipase in diabetes. Diabetes Metab Rev. 3:551-570.
19. Brunzell JD, Porte Jr D, Bierman EL. 1979 Abnormal lipoprotein-lipase-mediated plasma triglyceride removal in untreated diabetes mellitus associated with hypertriglyceridemia. Metabolism. 28:901-907.
20. Frénais R, Ouguerram K, Maugeais C, et al. 1997 High density lipoprotein apolipoprotein AI kinetics in NIDDM: a stable isotope study. Diabetologia. 40:578-583.
21. Pietzch J, Julius U, Nitzsche S, Hanefeld M. 1998 In vivo evidence for increased apolipoprotein A-I catabolism in subjects with impaired glucose tolerance. Diabetes, 47:1928-1934.
22. Chapman MJ, Goldstein S, Lagrange D, Laplaud PM. 1981 A density gradient ultracentrifugal procedure for the isolation of the major lipoprotein classes from human serum. J Lipid Res. 22:339-358.
23. Dagher FJ, Lyons JH, Finlayson DC, Shamsai J, Moore FD. 1965 Blood volume measurement: a critical study. Prediction of normal values, controlled measurement of sequential changes, choice of a bedside method. Adv Surg. 1:69-109.
24. Schaefer EJ, Zech LA, Jenkins LL, et al. 1982 Human apolipoprotein AI and AII metabolism. J Lipid Res. 23:850-862.
25. Mindham MA, and Mayes PA. 1992 A simple and rapid method for preparation of apolipoproteins for electrophoresis. J Lipid Res. 33:1084-1088.
26. Foster DM, Barrett PHR, Toffolo G, Beltz WF, Cobelli C. 1993 Estimating the fractional synthetic rate of plasma apolipoproteins and lipids from stable isotope data. J Lipid Res. 34:2193-2205.
27. Iverius PH, Brunzell JD. 1985 Human adipose tissue lipoprotein lipase: changes with feeding and relation to post-heparin plasma enzyme. Am J Physiol. 249:E107-E114.
28. Henderson A, Richmond W, Elkeles RS. 1993 Hepatic and lipoprotein lipases selectively assayed in postheparin plasma. Clin Chem. 39:218-223.
29. Matthews DR, Hosker JP, Rudenski BA, Naylor BA, Treacher DF, Turner RC. 1985 Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 28:412-419.
30. Ikewaki K, Rader DJ, Schaefer JR, Fairwell T, Zech LA, Brewer Jr HB. 1993 Evaluation of apo AI kinetics inhuman using simultaneous endogenous stable isotope and exogenous radiotracer methods. J Lipid Res. 34:2207-2215.
31. Shepherd J, Packard CJ, Patsch JR, Gotto AM, Taunton OD. 1978 Metabolism of apolipoprotein AI and AII and its influence on the high density lipoprotein subfraction distribution in males and females. Eur J Clin Invest. 8:115-120.
32. Brinton EA, Eisenberg S, Breslow JL. 1994 Human HDL cholesterol levels are determined by apo AI fractional catabolic rate, which correlates inversely with estimates of HDL particle size. Arterioscler Thromb. 14:707-720.
33. Osborne JC, Schaefer EJ, Powell GM, Lee NS, Zech LA. 1984 Molecular properties of radio-iodinated apolipoprotein AI. J Biol Chem. 259:347-353.
34. Walsh BW, Li H, Sacks FM. 1994 Effects of postmenopausal hormone replacement with oral and transdermal estrogen on high density lipoprotein metabolism. J Lipid Res. 35:2083-2093.
35. Howard BV. 1993 Diabetes and plasma lipoproteins in native Americans. Studies of the Pima Indians. Diab Care. 16:284-291.
36. Nikkilä EA, Huttunen JK, Ehnholm C. 1977 Postheparin plasma lipoprotein lipase and hepatic lipase in diabetes mellitus. Relationship to plasma triglycerides metabolism. Diabetes. 26:11-21.
37. Abbate SL, Brunzell JD. 1990 Pathophysiology of hyperlipidemia in diabetes mellitus. J Cardiol Pharmacol. 16:S1-S7.
38. Clee SM, Zhang H, Bissada N, et al. 1997 Relationship between lipoprotein lipase and high density lipoprotein cholesterol in mice: modulation by cholesteryl ester transfer protein and dietary status. J Lipid Res. 38:2079-2089.
39. Desprès JP, Ferland M, Moorjani S, et al. 1989 Role of hepatic-triglyceride lipase activity in the association between intra-abdominal fat and plasma HDL cholesterol in obese women. Arteriosclerosis. 9:485-492.
40. Biesbroeck RC, Albers JJ, Wahl PW, Weinberg CR, Bassett ML, Bierman EL. 1982 Abnormal composition of high density lipoproteins in noninsulin- dependent diabetics. Diabetes. 31:126-131.
41. Briones ER, Mao SJT, Palumbo PJ, O'Fallon WM, Chenoweth W, Kottke BA. 1984 Analysis of plasma lipids and apolipoproteins in insulin-dependent and noninsulin-dependent diabetics. Metabolism. 33:42-49.
42. Ahnadi CE, Masmoudi T, Berthézène F, Ponsin G. 1993 Decreased ability of high density lipoproteins to transfer cholesterol esters in noninsulin-dependent diabetes mellitus. Eur J Clin Invest. 23:191-196.
43. Dean JD, Owens DR, Matthews SB. 1990 Apolipoprotein and lipid ratio in treated noninsulin-dependent diabetics. Diabetes Res. 15:21-25.
44. Golay A, Zech L, Shi MZ, Chiou YAM, Reaven GM, Chen YDI. 1987 High density lipoprotein (HDL) metabolism in noninsulin-dependent diabetes mellitus: measurement of HDL turnover using tritiated HDL. J Clin Endocrinol Metab. 65:512-518.
45. Pollare T, Vessby B, Lithell H. 1991 Lipoprotein lipase activity in skeletal muscle is related to insulin sensitivity. Arterioscler Thromb. 11:1192-1203.
46. Maheux P, Azhar S, Kern PA, Chen YDI, Reaven GM. 1997 Relationship between insulin-mediated glucose disposal and regulation of plasma and adipose tissue lipoprotein lipase. Diabetologia. 40:850-858.
47. Staels B, Schoonjans K, Fruchart JC, Auwerx J. 1997 The effects of fibrates and thiazolidinediones on plasma triglyceride metabolism are mediated by distinct peroxisome proliferator activated receptors (PPARs). Biochimie. 79:95-99.